Background and study aims: Complete esophageal obstruction (CEO) is a rare occurrence characterized by progressive
esophageal stricture, which eventually causes lumen obliteration. With recent advances
in flexible endoscopy, various innovative techniques exist for restoring luminal continuity.
The primary aim of this study was to assess the efficacy and safety of patients undergoing
combined antegrade-retrograde endoscopic dilation for CEO at our institution. The
secondary aim was to review and highlight emerging techniques, outcomes, and adverse
events after endoscopic treatment of CEO.
Patients and methods: Our electronic endoscopy database was retrospectively reviewed to identify patients
who underwent combined antegrade and retrograde endoscopy for CEO. Patient and procedural
data collected included gender, age, technical success, pre- and post-dysphagia scores,
and adverse events.
Results: Six patients (67 % male, mean age 71.6 years [range 63 – 80]) underwent technically
successful esophageal reconstruction with combined antegrade-retrograde endoscopy.
All patients noted improvement in dysphagia with mean pre-procedure dysphagia score
of 4 reduced to 1.33 (range 0 – 3) post-procedure. There were no adverse events and
mean follow-up time was 17.3 months (range 3 – 48).
Conclusions: Combined antegrade and retrograde endoscopic therapy for CEO is feasible and safe.
We present our experience with endoscopic management of complete esophageal obstruction,
and highlight emerging techniques, outcomes and adverse events related to this minimally
invasive modality.